| Trial ID: | L6255 |
| Source ID: | NCT00609856
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Secondary Drug Failure
|
| Interventions: |
DRUG: pioglitazone|DRUG: insulin glargine
|
| Outcome Measures: |
Primary: Effect of pioglitazone vs. insulin glargine on beta-cell function and insulin sensitivity, 26 weeks | Secondary: Effect of pioglitazone vs. insulin glargine on BNP, 26 weeks
|
| Sponsor/Collaborators: |
Sponsor: Skane University Hospital | Collaborators: Medical Research Council|Skane County Council Research & Development Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-04
|
| Completion Date: |
2006-12
|
| Results First Posted: |
|
| Last Update Posted: |
2008-02-07
|
| Locations: |
Malmö University Hospital, Malmö, 20502, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT00609856
|
